Legis Daily

National Commission on the COVID–19 Pandemic Act

USA117th CongressHR-7069| House 
| Updated: 3/14/2022
Jackie Speier

Jackie Speier

Democratic Representative

California

Cosponsors (7)
Dwight Evans (Democratic)Michael C. Burgess (Republican)Dina Titus (Democratic)Danny K. Davis (Democratic)Don Bacon (Republican)Jim Costa (Democratic)Katie Porter (Democratic)

Health Subcommittee, Energy and Commerce Committee, Intelligence (Permanent Select) Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
National Commission on the COVID-19 Pandemic Act This bill temporarily establishes the National Commission on the COVID-19 Pandemic in the legislative branch to investigate the facts and circumstances regarding the emergence of, spread of, and response to COVID-19. The commission terminates 90 days after it submits a final report of its findings and recommendations.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 4, 2021

Latest Companion Bill Action

S 117-3203
Introduced in Senate
Mar 11, 2022
Introduced in House
Mar 11, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 14, 2022
Referred to the Subcommittee on Health.
  • November 4, 2021

    Latest Companion Bill Action

    S 117-3203
    Introduced in Senate


  • March 11, 2022
    Introduced in House


  • March 11, 2022
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • March 14, 2022
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 117-3203: National Commission on the COVID–19 Pandemic Act
Advisory bodiesAsiaCardiovascular and respiratory healthChemical and biological weaponsChinaCongressional operations and organizationCongressional oversightDisability and health-based discriminationEmergency medical services and trauma careGovernment studies and investigationsHealth facilities and institutionsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesIntelligence activities, surveillance, classified informationInternational organizations and cooperationMedical researchPublic contracts and procurementResearch administration and fundingStrategic materials and reservesWorker safety and healthWorld health

National Commission on the COVID–19 Pandemic Act

USA117th CongressHR-7069| House 
| Updated: 3/14/2022
National Commission on the COVID-19 Pandemic Act This bill temporarily establishes the National Commission on the COVID-19 Pandemic in the legislative branch to investigate the facts and circumstances regarding the emergence of, spread of, and response to COVID-19. The commission terminates 90 days after it submits a final report of its findings and recommendations.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 4, 2021

Latest Companion Bill Action

S 117-3203
Introduced in Senate
Mar 11, 2022
Introduced in House
Mar 11, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 14, 2022
Referred to the Subcommittee on Health.
  • November 4, 2021

    Latest Companion Bill Action

    S 117-3203
    Introduced in Senate


  • March 11, 2022
    Introduced in House


  • March 11, 2022
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • March 14, 2022
    Referred to the Subcommittee on Health.
Jackie Speier

Jackie Speier

Democratic Representative

California

Cosponsors (7)
Dwight Evans (Democratic)Michael C. Burgess (Republican)Dina Titus (Democratic)Danny K. Davis (Democratic)Don Bacon (Republican)Jim Costa (Democratic)Katie Porter (Democratic)

Health Subcommittee, Energy and Commerce Committee, Intelligence (Permanent Select) Committee

Health

Related Bills

  • S 117-3203: National Commission on the COVID–19 Pandemic Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Advisory bodiesAsiaCardiovascular and respiratory healthChemical and biological weaponsChinaCongressional operations and organizationCongressional oversightDisability and health-based discriminationEmergency medical services and trauma careGovernment studies and investigationsHealth facilities and institutionsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesIntelligence activities, surveillance, classified informationInternational organizations and cooperationMedical researchPublic contracts and procurementResearch administration and fundingStrategic materials and reservesWorker safety and healthWorld health